Dipna Pharmachem Share Price Today

Dipna Pharmachem Q1FY27 Results: Net profit down 31% YoY to ₹39.42 lakh

Net profit declined 30.87% YoY to ₹39.42 lakh in Q1FY27. Revenue from operations grew 9.89% YoY to ₹2,033.03 lakh. Current tax expense of ₹13.00 lakh impacted bottom line vs nil in prior year. Other operating income surged to ₹346.03 lakh from nil in Q1FY26.

Dipna Pharmachem appoints two new independent directors

Appointed Hiteshkumar Shankarlal Parmar and Swetal Nalinbhai Shah as Additional Independent Directors. Reconstituted Audit, Nomination and Remuneration, and Stakeholders Relationship Committees effective November 3, 2026. Hiteshkumar Shankarlal Parmar appointed as Chairperson for all three reconstituted committees. Both new directors hold commerce degrees with extensive business management experience.

Dipna Pharmachem appoints Nirav Soni, accepts two independent director resignations

Nirav Madhusudan Soni appointed as Additional Non-Executive and Non-Independent Director. Jitendra Parmar and Manish Bachani resigned as Independent Directors citing personal reasons. Soni appointed as Chairperson of Audit, Nomination, and Stakeholders Relationship Committees. Resigning directors hold multiple independent directorships in other listed companies.

Dipna Pharmachem appoints Shyam Sundar Lohia as company secretary

Dipna Pharmachem appointed Shyam Sundar Lohia as Company Secretary and Compliance Officer effective August 5, 2026. Lohia holds Membership No: A28706 and has over 12 years of experience in corporate governance and regulatory compliance. The appointment was approved by the Board during a meeting held at the Ahmedabad registered office. Lohia is not related to any of the directors of the company.

Dipna Pharmachem FY26 net profit rises 170% to ₹263.19 lakh

Dipna Pharmachem reported a 170.3% YoY rise in FY26 net profit to ₹263.19 lakh, with revenue increasing to ₹1,291.09 crore. Q4 net profit stood at ₹17.86 lakh. The Board approved the audited results on July 2, 2026, marking the first adoption of Ind AS.

Dipna Pharmachem independent director resigns effective June 10

Dipna Pharmachem Limited accepted the resignation of Nandish Shaileshbhai Jani as Non-Executive and Independent Director effective June 10, 2026. Jani cited personal reasons for stepping down and confirmed no other material reasons for his departure. He holds directorships in Magenta Lifecare Limited and AKI India Limited.